PrEP Decisional Aid for HIV Prevention

(DASH Trial)

This trial tests a new app designed to help individuals using HIV self-test kits learn about PrEP, a medication that prevents HIV, and decide if it suits them. By integrating this tool with self-testing, the trial aims to simplify understanding of options and access to PrEP if needed. Participants will be divided into two groups: one using the app and one not, to evaluate the app's effectiveness. This trial may suit those comfortable with English, with internet access, who are HIV negative, and have never used PrEP. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could simplify access to HIV prevention methods.

The trial information does not specify whether you need to stop taking your current medications. It focuses on people who have never used PrEP before.

Research has shown that the PrEP Decisional Aid (DASH app) helps people make informed decisions about using PrEP, a proven method to prevent HIV. Studies have demonstrated that PrEP is safe and effective, reducing the risk of contracting HIV by up to 99% when taken as directed. This makes it a well-accepted option for those at risk of HIV.

Researchers are excited about the PrEP Decisional Aid for dissemination with Self-administered HIV test kits (DASH) because it offers a novel approach to HIV prevention. Unlike traditional methods that rely on in-person consultations and guidance, DASH provides a digital tool that can be easily accessed through an app. This approach empowers individuals by offering them information and reminders in a user-friendly way, potentially increasing adherence to PrEP usage. The convenience and accessibility of this method could significantly enhance the reach and effectiveness of HIV prevention strategies, especially among populations that face barriers to accessing healthcare services.

Research shows that PrEP (pre-exposure prophylaxis) effectively prevents HIV when taken correctly. Studies indicate that daily PrEP use can reduce the risk of contracting HIV from sex by 99% and from injecting drugs by at least 74%. In this trial, participants in the DASH Intervention Arm will access the DASH app, which helps individuals decide if PrEP suits them by guiding them through the process and considering their personal needs and values. Previous research has shown that tools like this can increase PrEP use by identifying those at risk and encouraging them to start treatment. This method empowers users to take charge of their health and lower their risk of HIV infection.²³⁶⁷⁸